Gleason Group’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$8.4K Hold
2025
Q2
$13.8K Hold
2025
Q1
$14.7K Hold
2024
Q4
$10.2K Hold
2024
Q3
$13.3K Hold
2024
Q2
$23.3K Hold
2024
Q1
$18.5K Hold
2023
Q4
$11.3K Buy